Neurohumoral gate for the entry of coronavirus into the central nervous system through the cribriform plate of the skull

Recent research has shown that there are different drainage systems in the brain. During the drainage of cerebrospinal and interstitial fluids, intracerebral (intracranial) lymph is formed, which becomes part of the glymphatic system. Later, the glymphatic system was subdivided into periand paravascular spaces, but their existence has not yet been proven. The article contains data on the anatomy of the lamina cribrosa, its age-related changes, the characteristics of the lymphatic system and the theory of the existence of glymphatic vessels in this area. We also hypothesize that in addition to the classical view, which assumes that viruses enter the central nervous system (CNS) through the blood-brain barrier or with the help of immune cells, there are other routes of pathogen entry, for example through the glymphatic system. Possible routes of movement of cerebrospinal and interstitial fluids through the structures of the nervous system and other systems are considered. The lamina cribrosa is considered a possible portal of entry for viruses into the CNS, in particular for the SARS-CoV-2 virus. In our review, we analyzed the likely mechanisms of SARS-CoV-2 spread in the central nervous system and the possible consequences of previous viral disease.

1. Jackowski C, Bolliger S, Thali MJ. Common and unexpected findings in mummies from ancient Egypt and South America as revealed by CT. Radiographics. 2008 SepOct;28(5):1477-92. doi: 10.1148/rg.285075112

2. Viale GL, Deseri S, Gennaro S, Sehrbundt E. A craniocerebral infectious disease: case report on the traces of Hippocrates. Neurosurgery. 2002 Jun;50(6):1376-8; discussion 1378-9. doi: 10.1097/00006123-200206000-00034

3. Bucchieri F, Farina F, Zummo G, Cappello F. Lymphatic vessels of the dura mater: a new discovery? J Anat. 2015 Nov;227(5):702-3. doi: 10.1111/joa.12381. Epub 2015 Sep 18.

4. Schwalbe G. Der Arachnoidalraum, ein Lymphraum und sein Zusammenhang mit dem Perichoroidalraum. Zentralblatt für medizinische Wissenschaft. 1869;7:465-7.

5. Andres KH, von Düring M, Muszynski K, Schmidt RF. Nerve fibres and their terminals of the dura mater encephali of the rat. Anat Embryol (Berl). 1987;175(3):289-301. doi: 10.1007/BF00309843

6. Cserr HF, Knopf PM. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today. 1992 Dec;13(12):507-12. doi: 10.1016/01675699(92)90027-5

7. Kida S, Pantazis A, Weller RO. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol Appl Neurobiol. 1993 Dec;19(6):480-8. doi: 10.1111/j.1365-2990.1993.tb00476.x

8. Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015 Jun 29;212(7):991-9. doi: 10.1084/jem.20142290. Epub 2015 Jun 15.

9. Semyachkina-Glushkovskaya O, Postnov D, Kurths J. Blood{Brain Barrier, Lymphatic Clearance, and Recovery: Ariadne's Thread in Labyrinths of Hypotheses. Int J Mol Sci. 2018 Nov 30;19(12):3818. doi: 10.3390/ijms19123818

10. Engelhardt B, Carare RO, Bechmann I, et al. Vascular, glial, and lymphatic immune gateways of the central nervous system. Acta Neuropathol. 2016 Sep;132(3):317-38. doi: 10.1007/s00401-016-1606-5. Epub 2016 Aug 13.

11. Van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol. 2015 Jan;235(2):277-87. doi: 10.1002/path.4461

12. Mori I, Nishiyama Y, Yokochi T, Kimura Y. Olfactory transmission of neurotropic viruses. J Neurovirol. 2005 Apr;11(2):129-37. doi: 10.1080/13550280590922793

13. Vaira LA, Hopkins C, Petrocelli M, et al. Do olfactory and gustatory psychophysical scores have prognostic value in COVID-19 patients? A prospective study of 106 patients. J Otolaryngol Head Neck Surg. 2020 Aug 6;49(1):56. doi: 10.1186/s40463-020-00449-y

14. Vasvari G, Reisch R, Patonay L. Surgical anatomy of the cribriform plate and adjacent areas. Minim Invasive Neurosurg. 2005 Feb;48(1):25-33. doi: 10.1055/s-2004-830180

15. Kawahara G, Matsuda M, Sugiyama K, et al. [Studies on the Japanese lamina cribrosa – statistical observation on its shape, number of pores and area]. Zasshi Tokyo Ika Daigaku. 1968 Mar;26(1):185-94 (In Jap.).

16. Williams PL, Bannister LH, Berry MM, et аl. Gray's Anatomy. 38th ed. Edinburgh: Churchill Livingston; 1995.

17. Kainz J, Stammberger H. The Roof of the Anterior Ethmoid: A Place of Least Resistance in the Skull Base. Am J Rhinol. 1989 Sep 1;3(4):191-9.

18. Stieda L. Über den Sulcus ethmoidalis der Lamina cribrosa des Siebbeins. Anat Anz. 1891;8:232-7.

19. Mihalkovics G. Anatomie und Entwicklungsgeschickte der Nase und ihrer Nebenhöhlen. In: Handbuch der Laryngologie und Rhinologie. Wien; 1896.

20. Wolfgruber H. Über die Lamina cribrosa des Ethmoids. Z Laryngol Rhinol Otol Ihre Grenzgeb. 1968;47:522-9.

21. Lauralee S. Human Physiology from Cells to Systems. 8th ed. Scarborough, Canada: Nelson Education; 2015.

22. Nikolenko VN, Oganesyan MV, Vovkogon AD, et al. Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases. Curr Neuropharmacol. 2020;18(11):1054-63. doi: 10.2174/1570159X17666191113103850

23. Lohrberg M, Wilting J. The lymphatic vascular system of the mouse head. Cell Tissue Res. 2016 Dec;366(3):667-77. doi: 10.1007/s00441-016-2493-8. Epub 2016 Sep 6.

24. Burdey GD. On the variability of mastoid graduates and jugular foramina. In: Trudy Kafedry normal'noy anatomii Saratovskogo gosudarstvennogo meditsinskogo instituta. Vyp. 1. Voprosy izmenchivosti kostnoy i sosudistoy sistem cheloveka [Proceedings of the Department of Normal Anatomy of the Saratov State Medical Institute. Vol. 1. Issues of variability of human bone and vascular systems]. Saratov; 1955. P. 23-36 (In Russ.).

25. Dolzhikov AA, Bobyntsev II, Belykh AE, et al. Pathogenesis of neurodegenerative pathology and new concepts of transport and metabolic systems of the brain and eye. Kurskii nauchnoprakticheskii vestnik “Chelovek i ego zdorov'e” = Kursk Scientific and Practical Bulletin “Man and His Health”. 2020;(1):43-57. doi: 10.21626/vestnik/2020-1/06 (In Russ.).

26. Lobzin VYu, Kolmakova KA, Emelin AYu, Lapina AV. Glymphatic brain system and its role in pathogenesis of Alzheimer's disease. Vestnik Rossiyskoy voyenno-meditsinskoy akademii. 2019;1(65):230-6 (In Russ.).

27. Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012 Aug 15;4(147):147ra111. doi: 10.1126/scitranslmed.3003748

28. Nikolenko VN, Oganesyan MV, Yakhno NN, et al. The brain's glymphatic system: physiological anatomy and clinical perspectives. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(4):94-100. doi: 10.14412/2074-27112018-4-94-100 (In Russ.).

29. Bedussi B, van der Wel NN, de Vos J, et al. Paravascular channels, cisterns, and the subarachnoid space in the rat brain: A single compartment with preferential pathways. J Cereb Blood Flow Metab. 2017 Apr;37(4):1374-85. doi: 10.1177/0271678X16655550. Epub 2016 Jan 1.

30. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1-23. doi: 10.1007/978-1-4939-2438-7_1

31. Allen AM et al. Neuronal angiotensin. In: Squire LR, ed. Encyclopedia of Neuroscience. New York: Academic Press; 2009. P. 697-702.

32. Iroegbu JD, Ifenatuoha CW, Ijomone OM. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2. Neurol Sci. 2020 Jun;41(6):1329-37. doi: 10.1007/s10072-020-04469-4. Epub 2020 May 18.

33. Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci. 2020 Jul;77:8-12. doi: 10.1016/j.jocn.2020.05.017. Epub 2020 May 6.

34. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020 Jun;92(6):552-5. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.

35. Chen BP, Lane TE. Lack of nitric oxide synthase type 2 (NOS2) results in reduced neuronal apoptosis and mortality following mouse hepatitis virus infection of the central nervous system. J Neurovirol. 2002 Feb;8(1):58-63. doi: 10.1080/135502802317247820

36. Berger JR. COVID-19 and the nervous system. J Neurovirol. 2020 Apr;26(2):143-8. doi: 10.1007/s13365-020-00840-5. Epub 2020 May 23.

37. Swanson PA 2nd, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015 Apr;11:44-54. doi: 10.1016/j.coviro.2014.12.009. Epub 2015 Feb 12.

38. Tyler KL. Acute Viral Encephalitis. N Engl J Med. 2018 Aug 9;379(6):557-66. doi: 10.1056/NEJMra1708714

39. Forrester JV, McMenamin PG, Dando SJ. CNS infection and immune privilege. Nat Rev Neurosci. 2018 Nov;19(11):655-71. doi: 10.1038/s41583-018-0070-8

40. McGavern DB, Kang SS. Illuminating viral infections in the nervous system. Nat Rev Immunol. 2011 May;11(5):318-29. doi: 10.1038/nri2971

41. Grass GD, Toole BP. How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Biosci Rep. 2015 Nov 24;36(1):e00283. doi: 10.1042/BSR20150256

42. Kanyenda LJ, Verdile G, Boulos S, et al. The dynamics of CD147 in Alzheimer's disease development and pathology. J Alzheimers Dis. 2011;26(4):593-605. doi: 10.3233/JAD-2011110584

43. Murphy C, Doty RL, Duncan HJ. Clinical disorders of olfaction. In: Handbook of Olfaction and Gustation. New York; Basel: Dekker; 2003. P. 461-78.

44. Voznesenskaya AE, Klyuchnikova MA, Rodionova EI, Voznessenskaya VV. Olfactory dysfunction in neurodegenerative diseases. Sensornie systemi. 2011;25(1):17-31 (In Russ.).

45. Rodrigues Prestes TR, Rocha NP, Miranda AS, et al. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research. Curr Drug Targets. 2017;18(11):1301-13. doi: 10.2174/1389450117666160727142401

46. Barrios AW, Nunez G, Sanchez Quinteiro P, Salazar I. Anatomy, histochemistry, and immunohistochemistry of the olfactory subsystems in mice. Front Neuroanat. 2014 Jul 14;8:63. doi: 10.3389/fnana.2014.00063

47. Chigr F, Merzouki M, Najimi M. Comment on “The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients”. J Med Virol. 2020 Jul;92(7):703-4. doi: 10.1002/jmv.25960. Epub 2020 May 22.

48. Patterson CE, Lawrence DM, Echols LA, Rall GF. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol. 2002 May;76(9):4497506. doi: 10.1128/jvi.76.9.4497-4506.2002

49. Tishon A, Lewicki H, Andaya A, et. al. CD4 T cell control primary measles virus infection of the CNS: Regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective. J Virol. 2006 Mar; 30;347(1):234-45. doi: 10.1016/j.virol.2006.01.050

50. Liu T, Khanna KM, Carriere BN, Hendricks RL. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol. 2001 Nov;75(22):11178-84. doi: 10.1128/JVI.75.22.11178-11184.2001

51. Cantin EM, Hinton DR, Chen J, Openshaw H. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol. 1995 Aug;69(8):4898-905. doi: 10.1128/JVI.69.8.4898-4905.1995

52. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol. 2001;19:65-91. doi: 10.1146/annurev.immunol.19.1.65

53. Gilles PN, Fey G, Chisari FV. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol. 1992 Jun;66(6):3955-60. doi: 10.1128/JVI.66.6.3955-3960.1992

54. Lauterbach H, Zuniga EI, Truong P, et al. Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection. J Exp Med. 2006 Aug 7;203(8):196375. doi: 10.1084/jem.20060039. Epub 2006 Jul 17.

55. Stevens JC, Dadarwala AD. Variability of olfactory threshold and its role in assessment of aging. Percept Psychophys. 1993 Sep;54(3):296-302. doi: 10.3758/bf03205264. Erratum in: Percept Psychophys. 1993 Oct;54(4):562.

56. Doty RL. Olfaction. Annu Rev Psychol. 2001;52:423-52. doi: 10.1146/annurev.psych.52.1.423

57. Kalmey JK, Thewissen JG, Dluzen DE. Age-related size reduction of foramina in the cribriform plate. Anat Rec. 1998 Jul;251(3):326-9. doi: 10.1002/(SICI)10970185(199807)251:3<326::AIDAR7>3.0.CO;2-T